SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-026389
Filing Date
2016-10-27
Accepted
2016-10-27 16:43:38
Documents
41
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q crxm-10q_20150930.htm 10-Q 761106
2 EX-31.1 crxm-ex311_10.htm EX-31.1 10208
3 EX-32 crxm-ex32_11.htm EX-32 5527
  Complete submission text file 0001564590-16-026389.txt   3483207

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT crxm-20150930.xml EX-101.INS 571200
5 XBRL TAXONOMY EXTENSION SCHEMA crxm-20150930.xsd EX-101.SCH 38911
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crxm-20150930_cal.xml EX-101.CAL 23120
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crxm-20150930_def.xml EX-101.DEF 132872
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE crxm-20150930_lab.xml EX-101.LAB 289821
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crxm-20150930_pre.xml EX-101.PRE 210271
Mailing Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121
Business Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121 (858) 436-1000
Taxus Cardium Pharmaceuticals Group Inc. (Filer) CIK: 0000772320 (see all company filings)

IRS No.: 840635673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33635 | Film No.: 161956029
SIC: 2836 Biological Products, (No Diagnostic Substances)